牛牛AI助理已提取核心訊息
Tonix Pharmaceuticals Holding Corp. announced on January 25, 2024, that it has successfully amended its Articles of Incorporation to increase the number of authorized shares of common stock from 160 million to 1 billion. The amendment, known as the Charter Amendment, was approved by shareholders during a special meeting held on the same day. The approval was part of two proposals voted on by shareholders, with the first proposal regarding the increase of shares receiving significant support, with 34,691,460 votes for and 4,827,447 against. The second proposal, which allowed for the adjournment of the meeting to solicit additional proxies if necessary, also passed. The changes were filed with the Secretary of State of Nevada, as detailed in the company's Form 8-K report to the Securities and Exchange Commission.
Tonix Pharmaceuticals Holding Corp. announced on January 25, 2024, that it has successfully amended its Articles of Incorporation to increase the number of authorized shares of common stock from 160 million to 1 billion. The amendment, known as the Charter Amendment, was approved by shareholders during a special meeting held on the same day. The approval was part of two proposals voted on by shareholders, with the first proposal regarding the increase of shares receiving significant support, with 34,691,460 votes for and 4,827,447 against. The second proposal, which allowed for the adjournment of the meeting to solicit additional proxies if necessary, also passed. The changes were filed with the Secretary of State of Nevada, as detailed in the company's Form 8-K report to the Securities and Exchange Commission.
Tonix Pharmicals Holding Corp. 於2024年1月25日宣佈，它已成功修改其公司章程，將普通股的授權數量從1.6億股增加到10億股。該修正案被稱爲《章程修正案》，在當天舉行的特別會議上獲得股東的批准。該批准是股東投票表決的兩項提案的一部分，第一項關於增加股份的提案獲得了大量支持，34,691,460票贊成，4,827,447票反對。第二項提案也獲得通過，該提案允許休會，以便在必要時徵集更多代理人。這些變更已向內華達州國務卿提交，詳見該公司向美國證券交易委員會提交的8-K表報告。
Tonix Pharmicals Holding Corp. 於2024年1月25日宣佈，它已成功修改其公司章程，將普通股的授權數量從1.6億股增加到10億股。該修正案被稱爲《章程修正案》，在當天舉行的特別會議上獲得股東的批准。該批准是股東投票表決的兩項提案的一部分，第一項關於增加股份的提案獲得了大量支持，34,691,460票贊成，4,827,447票反對。第二項提案也獲得通過，該提案允許休會，以便在必要時徵集更多代理人。這些變更已向內華達州國務卿提交，詳見該公司向美國證券交易委員會提交的8-K表報告。
有用
沒用